Abstract |
We describe a 63-yr-old man with disseminated medullary carcinoma of the thyroid and pancreatic nesidioblastosis and microadenosis with pancreatic polypeptide (PP) hypersecretion. His major symptoms were watery diarrhea, flushing, and abdominal bloating; these and the elevated plasma PP levels did not change after resection of the distal two thirds of the pancreas, which contained a 2-cm mass of nesidioblastotic tissue. Postoperatively, a long-acting somatostatin analog, SMS 201-995 (100 micrograms/day), normalized PP secretion acutely and chronically (7 months) and ameliorated his symptoms. The analog had no side-effects and did not alter glucose tolerance, calcitonin hypersecretion, or growth of the medullary carcinoma, but it did inhibit GH secretion. After withdrawal from therapy for 1 month, PP hypersecretion and all symptoms except diarrhea recurred. The coexistence of medullary carcinoma of the thyroid and PP cell nesidioblastosis represents a new variant of the overlap syndromes between multiple endocrine neoplasia types I and II. Patients with medullary carcinoma and unexplained watery diarrhea should have fasting gastroenteropancreatic hormone assays done to screen for a potential gastrointestinal or pancreatic origin for the diarrhea.
|
Authors | T W Jerkins, H S Sacks, T M O'Dorisio, S Tuttle, S S Solomon |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 64
Issue 6
Pg. 1313-9
(Jun 1987)
ISSN: 0021-972X [Print] United States |
PMID | 2883196
(Publication Type: Case Reports, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Peptides
- Somatostatin
- Calcitonin
- Octreotide
|
Topics |
- Calcitonin
(metabolism)
- Carcinoma
(complications, pathology)
- Eating
- Humans
- Immunochemistry
- Liver Circulation
- Male
- Middle Aged
- Octreotide
- Pancreas
(abnormalities, metabolism, pathology)
- Pancreatic Diseases
(complications, pathology)
- Peptides
(blood, metabolism)
- Portal Vein
- Somatostatin
(analogs & derivatives, therapeutic use)
- Thyroid Neoplasms
(complications, pathology)
|